[Pharmacokinetics of 3,7-dimethyl-1-(5-oxo-hexyl)-xanthine (BL 191) in man].
D000284:Administration, Oral; D002855:Chromatography, Thin Layer; D006207:Half-Life; D000441:Hexanols / Q000097:blood; D006801:Humans; D007275:Injections, Intravenous; D007408:Intestinal Absorption; D007659:Ketones / Q000008:administration & dosage / Q000097:blood / Q000378:metabolism / Q000652:urine; D008722:Methods; D013053:Spectrophotometry; D013608:Tablets, Enteric-Coated; D014665:Vasodilator Agents / Q000378:metabolism*; D014970:Xanthines / Q000008:administration & dosage / Q000097:blood / Q000378:metabolism* / Q000652:urine
D000441:Hexanols; D007659:Ketones; D013608:Tablets, Enteric-Coated; D014665:Vasodilator Agents; D014970:Xanthines
Zur Pharmakokinetik von 3,7-Dimethyl-1-(5-oxo-hexyl)-xanthin (BL 191) am Menschen.